CorMedix Inc. is a biopharmaceutical company based in Berkeley Heights Twp, NJ, dedicated to developing and commercializing therapeutic products for the prevention and treatment of life-threatening conditions and diseases. Their focus lies in reducing and treating infectious and inflammatory diseases, with a particular emphasis on catheter-related bloodstream infections (CRBSIs) in adult hemodialysis patients.
With a strong commitment to research and development, CorMedix Inc. has gained FDA approval for their product, DefenCath, which aims to reduce the incidence of CRBSIs in hemodialysis patients. Through their innovative pipeline and early science initiatives, the company strives to provide therapeutic options that address critical medical needs and improve patient outcomes.
Generated from the website